A new North American noctuid of the genus Anomogyna (Insecta, Lepitdoptera)

A comparative study of the North American species formerly referred to Anomogyna sincera H.-S. and of essentially typical sincera from Sweden has revealed a number of dissimilarities…

A revision of the moths of the subfamily Geometrinae of America North of Mexico (Insecta, Lepidoptera)

A new classification of the Geometrinae of the United States and Canada is presented, based largely on original investigations of male and female genitalia and larval characters….https://elischolar.library.yale.edu/peabody_museum_natural_history_bulletin/1028/thumbnail.jp

Microlepidoptera

11 p. : ill. ; 24 cm.Includes bibliographical references

Promiscuous actions of small molecule inhibitors of the protein kinase D-class IIa HDAC axis in striated muscle

AbstractPKD-mediated phosphorylation of class IIa HDACs frees the MEF2 transcription factor to activate genes that govern muscle differentiation and growth. Studies of the regulation and function of this signaling axis have involved MC1568 and Gö-6976, which are small molecule inhibitors of class IIa HDAC and PKD catalytic activity, respectively. We describe unanticipated effects of these compounds. MC1568 failed to inhibit class IIa HDAC catalytic activity in vitro, and exerted divergent effects on skeletal muscle differentiation compared to a bona fide inhibitor of these HDACs. In cardiomyocytes, Gö-6976 triggered calcium signaling and activated stress-inducible kinases. Based on these findings, caution is warranted when employing MC1568 and Gö-6976 as pharmacological tool compounds to assess functions of class IIa HDACs and PKD

Reprogramming of Trypanosoma cruzi metabolism triggered by parasite interaction with the host cell extracellular matrix.

Trypanosoma cruzi, the etiological agent of Chagas' disease, affects 8 million people predominantly living in socioeconomic underdeveloped areas. T. cruzi trypomastigotes (Ty), the classical infective stage, interact with the extracellular matrix (ECM), an obligatory step before invasion of almost all mammalian cells in different tissues. Here we have characterized the proteome and phosphoproteome of T. cruzi trypomastigotes upon interaction with ECM (MTy) and the data are available via ProteomeXchange with identifier PXD010970. Proteins involved with metabolic processes (such as the glycolytic pathway), kinases, flagellum and microtubule related proteins, transport-associated proteins and RNA/DNA binding elements are highly represented in the pool of proteins modified by phosphorylation. Further, important metabolic switches triggered by this interaction with ECM were indicated by decreases in the phosphorylation of hexokinase, phosphofructokinase, fructose-2,6-bisphosphatase, phosphoglucomutase, phosphoglycerate kinase in MTy. Concomitantly, a decrease in the pyruvate and lactate and an increase of glucose and succinate contents were detected by GC-MS. These observations led us to focus on the changes in the glycolytic pathway upon binding of the parasite to the ECM. Inhibition of hexokinase, pyruvate kinase and lactate dehydrogenase activities in MTy were observed and this correlated with the phosphorylation levels of the respective enzymes. Putative kinases involved in protein phosphorylation altered upon parasite incubation with ECM were suggested by in silico analysis. Taken together, our results show that in addition to cytoskeletal changes and protease activation, a reprogramming of the trypomastigote metabolism is triggered by the interaction of the parasite with the ECM prior to cell invasion and differentiation into amastigotes, the multiplicative intracellular stage of T. cruzi in the vertebrate host

The Herschel view of the dominant mode of galaxy growth from z=4 to the present day

We present an analysis of the deepest Herschel images in four major extragalactic fields GOODS-North, GOODS-South, UDS and COSMOS obtained within the GOODS-Herschel and CANDELS-Herschel key programs. The picture provided by 10497 individual far-infrared detections is supplemented by the stacking analysis of a mass-complete sample of 62361 star-forming galaxies from the CANDELS-HST H band-selected catalogs and from two deep ground-based Ks band-selected catalogs in the GOODS-North and the COSMOS-wide fields, in order to obtain one of the most accurate and unbiased understanding to date of the stellar mass growth over the cosmic history. We show, for the first time, that stacking also provides a powerful tool to determine the dispersion of a physical correlation and describe our method called "scatter stacking" that may be easily generalized to other experiments. We demonstrate that galaxies of all masses from z=4 to 0 follow a universal scaling law, the so-called main sequence of star-forming galaxies. We find a universal close-to-linear slope of the logSFR-logM* relation with evidence for a flattening of the main sequence at high masses (log(M*/Msun) > 10.5) that becomes less prominent with increasing redshift and almost vanishes by z~2. This flattening may be due to the parallel stellar growth of quiescent bulges in star-forming galaxies. Within the main sequence, we measure a non varying SFR dispersion of 0.3 dex. The specific SFR (sSFR=SFR/M*) of star-forming galaxies is found to continuously increase from z=0 to 4. Finally we discuss the implications of our findings on the cosmic SFR history and show that more than 2/3 of present-day stars must have formed in a regime dominated by the main sequence mode. As a consequence we conclude that, although omnipresent in the distant Universe, galaxy mergers had little impact in shaping the global star formation history over the last 12.5 Gyr

Targeting Functional Decline: Results from the Alzheimer’s Disease Multiple Intervention Trial

Background Alzheimer’s disease (AD) results in progressive functional decline leading to loss of independence Objective To determine whether collaborative care plus two years of home-based occupational therapy delays functional decline Design Randomized controlled clinical trial Setting Urban public health system Patients 180 community-dwelling subjects who were diagnosed with AD and their informal caregivers Interventions All subjects received collaborative care for dementia. Intervention patients also received in-home occupational therapy delivered in 24 sessions over 2 years. Measurements The primary outcome measures was the Alzheimer’s Disease Cooperative Studies Group Activities of Daily Living Scale (ADCS ADL); performance based measures included the Short Physical Performance Battery (SPPB) and Short Portable Sarcopenia Measure (SPSM) Results At baseline, there were no significant between group differences in clinical characteristics; the mean MMSE for both groups was 19 (SD=7). The intervention group received a median of 18 home visits from the study occupational therapists. Both groups declined in ADCS ADL scores over 24 months. At the primary endpoint of 24 months, there were no between group differences in ADCS ADL scores (mean difference 2.34, 95% CI −5.27, 9.96). We were also unable to definitively demonstrate between-group differences in the mean SPPB or SPSM. Limitations The results of this trial are indeterminate and do not rule out potentially clinically important effects of the intervention. Conclusions We were unable to definitively demonstrate whether the addition of two years of in-home occupational therapy to a collaborative care management model slows the rate of functional decline among persons with AD. This trial underscores the burden undertaken by family caregivers as they provide care for persons with AD and the difficulty in slowing functional decline